Buds & Duds: Cannabis stocks steady; XPhyto flies on C$2M financing for EU expansion

XPhyto said it plans to expand its EU lab processing and storage capacity

pot leaf stocks
Curaleaf closed its acquisition of vape manufacturer Select

Cannabis stocks held steady on Monday after last week’s declines across North America.

The North American Marijuana Index, which tracks the top cannabis stocks in the US and Canada, sank 2.1% at 109.3 points. Elsewhere, the Horizons Marijuana Life Sciences Index ETF lost 1.4% at C$8.90, while the OTCQX Cannabis index decreased by 1.5% to 459.7 points.


XPhyto Therapeutics Corp (CSE:XPHY) (OTCMKTS:XPHYF) jumped higher after it said it had raised C$2 million gross from a fully subscribed private placing to fund its European imports business.

The group said it plans to expand its EU lab processing and storage capacity. Funds will also be used for regulatory compliance, inventory purchase and product development, manufacturing, and distribution, as well as for working capital.

Investors reacted positively to the news, sending shares up 12% in Canada at C$1.78. Its over the counter shares traded at US$1.20.

Curaleaf Holdings Inc (CSE:CURA) (OTCMKTS:CURLF) closed its acquisition of vape company Select on Monday, with shares inching up 0.9% to C$9.47 and 0.4% to US$7.13.


With not a lot of movement in the sector, a few companies found their share prices in the red to start the month of February.

Tilray Inc (NASDAQ:TLRY) was down 2.7% at US$17.07, while Canopy Growth Corp (TSE:WEED) (NYSE:CGC) was also down 1.3% at C$29.41 and 1.9% at US$22.12.

As for small caps, FluroTech Ltd (CVE:TEST) (OTCMKTS:FLURF) sank 13.3% at C$0.13 and Vivo Cannabis Inc (TSE:VIVO) (OTCMKTS:VVCIF) lost 9.1% at C$0.30 and 6.1% at US$0.23.

Contact Angela at angela@proactiveinvestors.com

Follow her on Twitter @AHarmantas

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of XPhyto Therapeutics Corp. named herein, including the promotion by the Company of XPhyto Therapeutics Corp. in any Content on the Site, the...


Tetra Bio-Pharma acquires Canadian rights to Dronabinol Soft Gel capsules,...

Tetra Bio-Pharma Inc. (TSX:TBP) (OTCQB:TBPMF) Chief Commercial Officer Steeve Néron tells Proactive the biotech has acquired the Canadian exclusive rights for Dronabinol Soft Gel capsules, cannabinoid derived prescription drug aimed to treat AIDS-related anorexia and severe nausea and vomiting...

36 minutes ago

2 min read